Literature DB >> 2511175

Increased expression of ras genes in non-Hodgkin's lymphomas is not associated with oncogenic activation of those genes by point mutation.

K Hamatani1, Y Nagata, M Abe, K Abe, H Toki, S Ikeda, E Nakayama, H Shiku.   

Abstract

Twenty-three cases of non-Hodgkin's lymphoma (NHL) were analyzed for expression of ras genes by in situ hybridization utilizing biotinylated DNA probes. Increased expression of Ki-ras, Ha-ras and N-ras genes was observed in 12 cases, 6 cases and 1 case of NHL, respectively. Genomic DNA extracted from these 23 cases of NHL was region-specifically amplified by means of polymerase chain reaction to examine the presence of point mutations at the 12th, 13th and 61st codons of Ki-, Ha- and N-ras genes. Dot hybridization assays with appropriate oligonucleotide probes showed no evidence of point mutation in any case of NHL examined. These results indicate that increased expression of ras genes in NHL is not associated with ras gene activation by point mutation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2511175      PMCID: PMC5917838          DOI: 10.1111/j.1349-7006.1989.tb01701.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  15 in total

1.  Detection of high incidence of K-ras oncogenes during human colon tumorigenesis.

Authors:  K Forrester; C Almoguera; K Han; W E Grizzle; M Perucho
Journal:  Nature       Date:  1987 May 28-Jun 3       Impact factor: 49.962

2.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.

Authors:  R K Saiki; S Scharf; F Faloona; K B Mullis; G T Horn; H A Erlich; N Arnheim
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

3.  c-K-ras mutations in human carcinomas occur preferentially in codon 12.

Authors:  L Yanez; J Groffen; D M Valenzuela
Journal:  Oncogene       Date:  1987       Impact factor: 9.867

4.  Prevalence of ras gene mutations in human colorectal cancers.

Authors:  J L Bos; E R Fearon; S R Hamilton; M Verlaan-de Vries; J H van Boom; A J van der Eb; B Vogelstein
Journal:  Nature       Date:  1987 May 28-Jun 3       Impact factor: 49.962

Review 5.  ras genes.

Authors:  M Barbacid
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

6.  Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung.

Authors:  S Rodenhuis; R J Slebos; A J Boot; S G Evers; W J Mooi; S S Wagenaar; P C van Bodegom; J L Bos
Journal:  Cancer Res       Date:  1988-10-15       Impact factor: 12.701

7.  Expression of c-myc oncogene product and ras family oncogene products in various human malignant lymphomas defined by immunohistochemical techniques.

Authors:  S Mitani; I Sugawara; H Shiku; S Mori
Journal:  Cancer       Date:  1988-11-15       Impact factor: 6.860

8.  Analysis of RAS gene mutations in acute myeloid leukemia by polymerase chain reaction and oligonucleotide probes.

Authors:  C J Farr; R K Saiki; H A Erlich; F McCormick; C J Marshall
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

Review 9.  The ras gene family and human carcinogenesis.

Authors:  J L Bos
Journal:  Mutat Res       Date:  1988-05       Impact factor: 2.433

10.  A dot-blot screening procedure for mutated ras oncogenes using synthetic oligodeoxynucleotides.

Authors:  M Verlaan-de Vries; M E Bogaard; H van den Elst; J H van Boom; A J van der Eb; J L Bos
Journal:  Gene       Date:  1986       Impact factor: 3.688

View more
  2 in total

1.  Point mutations of c-ras genes in human bladder cancer and kidney cancer.

Authors:  Y Nagata; M Abe; K Kobayashi; S Saiki; T Kotake; K Yoshikawa; R Ueda; E Nakayama; H Shiku
Journal:  Jpn J Cancer Res       Date:  1990-01

2.  Infrequent ras mutation in human stomach cancers.

Authors:  M Koshiba; O Ogawa; T Habuchi; S Hamazaki; T Shimada; R Takahashi; T Sugiyama
Journal:  Jpn J Cancer Res       Date:  1993-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.